help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Busch, K.
Right arrow Articles by Muller, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Busch, K.
Right arrow Articles by Muller, M.
Molecular Endocrinology 14 (2): 201-211
Copyright © 2000 by The Endocrine Society

Silencing Subdomains of v-ErbA Interact Cooperatively with Corepressors: Involvement of Helices 5/6

Kerstin Busch, Bernd Martin1, Aria Baniahmad, Joseph A. Martial, Rainer Renkawitz and Marc Muller

Laboratoire de Biologie Moléculaire et de Génie Génétique (K.B., B.M., J.A.M., M.M.) Institut de Chimie-B6 Université de Liège B-4000 Liège, Belgium
Genetisches Institut (K.B., A.B., R.R.) Justus-Liebig-Universität D-35392 Giessen, Germany

Members of the thyroid hormone receptor (TR) family act on vertebrate development and homeostasis by activating or repressing transcription of specific target genes in a ligand-dependent way. Repression by TR in the absence of ligand is mediated by an active silencing mechanism. The oncogene v-ErbA is a variant form of TR unable to bind hormone and thus acts as a constitutive repressor. Functional studies and mutation analysis revealed that the TR/v-ErbA silencing domain is composed of three silencing subdomains (SSD1–3) which, although nonfunctional individually, synergize such that silencing activity is restored when they are combined in a heteromeric complex. Here we demonstrate, using protein interaction assays in vitro and in vivo, that the inactive v-ErbA point mutant L489R within helix 5/6 in SSD2 fails to interact with the two corepressors N-CoR (nuclear receptor corepressor) or SMRT (silencing mediator of retinoic acid and thyroid hormone receptor). Furthermore, mutants in SSD1 and SSD3 exhibit a reduced corepressor recruitment corresponding to their weak residual silencing activity. In mammalian two-hybrid assays, only the combination of all three silencing subdomains, SSD1–3, leads to a cooperative binding to the corepressors N-CoR or SMRT comparable to that of the full-length v-ErbA repression domain. In conclusion, full silencing activity requires corepressor interaction with all three silencing subdomains, SSD1–3. Among these, SSD2 is a new target for N-CoR and SMRT and is essential for corepressor binding and function.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
Q. Wang, J. A. Blackford Jr., L.-N. Song, Y. Huang, S. Cho, and S. S. Simons Jr.
Equilibrium Interactions of Corepressors and Coactivators with Agonist and Antagonist Complexes of Glucocorticoid Receptors
Mol. Endocrinol., June 1, 2004; 18(6): 1376 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Schulz, M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel, and R. Renkawitz
RU486-induced Glucocorticoid Receptor Agonism Is Controlled by the Receptor N Terminus and by Corepressor Binding
J. Biol. Chem., July 12, 2002; 277(29): 26238 - 26243.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Dotzlaw, U. Moehren, S. Mink, A. C. B. Cato, J. A. Iniguez Lluhi, and A. Baniahmad
The Amino Terminus of the Human AR Is Target for Corepressor Action and Antihormone Agonism
Mol. Endocrinol., April 1, 2002; 16(4): 661 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. D. Love, J. T. Gooch, S. Benko, C. Li, L. Nagy, V. K. K. Chatterjee, R. M. Evans, and J. W. R. Schwabe
The Structural Basis for the Specificity of Retinoid-X Receptor-selective Agonists: New Insights Into the Role of Helix H12
J. Biol. Chem., March 22, 2002; 277(13): 11385 - 11391.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. Jepsen and M. G. Rosenfeld
Biological roles and mechanistic actions of co-repressor complexes
J. Cell Sci., February 15, 2002; 115(4): 689 - 698.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Aranda and A. Pascual
Nuclear Hormone Receptors and Gene Expression
Physiol Rev, July 1, 2001; 81(3): 1269 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Webb, C. M. Anderson, C. Valentine, P. Nguyen, A. Marimuthu, B. L. West, J. D. Baxter, and P. J. Kushner
The Nuclear Receptor Corepressor (N-CoR) Contains Three Isoleucine Motifs (I/LXXII) That Serve as Receptor Interaction Domains (IDs)
Mol. Endocrinol., December 1, 2000; 14(12): 1976 - 1985.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Q. Shen and J. S. Subauste
Dimerization Interfaces of v-ErbA Homodimers and Heterodimers with Retinoid X Receptor alpha
J. Biol. Chem., December 22, 2000; 275(52): 41018 - 41027.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society